Source: Investing.com ↗

Inhibrx director Jon Kayyem buys $567,580 in company stock

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

BTC/USDT

$65,778.78

-4.51%

USDC/USDT

$1.00

-0.01%

ETH/USDT

$1,834.71

-5.38%

SOL/USDT

$72.49

-9.43%

ZEC/USDT

$850.97

-9.90%